Logo Image
NEWS
All NewsFDA BriefsOncology IconsThe Targeted Pulse
CONFERENCES
Conference CoverageConference Listing
MEDIA
All VideosCase-Based Peer PerspectivesEvolving Paradigms in OncologyExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesPodcastsPractice PlaybookShortsVideo SeriesWebinars
PUBLICATIONS
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
More
CASE-BASED ROUNDTABLE
PARTNERS
RESOURCES
CME/CEClinical TrialsEventsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
  • NEWS
  • CONFERENCES
  • MEDIA
  • PUBLICATIONS
  • CASE-BASED ROUNDTABLE
  • PARTNERS
  • RESOURCES
  • SUBSCRIBE
  • BRAIN CANCER
  • BREAST CANCER
    • HER2 Breast Cancer
  • COMMUNITY ONCOLOGY PRACTICE
  • GENITOURINARY CANCERS
    • Bladder Cancer
    • Prostate Cancer
    • Renal Cell Carcinoma
  • GENOMIC TESTING
    • Liquid Biopsies
  • GI CANCERS
    • Pancreatic Cancer
    • Colorectal Cancer
    • Gastric Cancer
    • GIST
    • HCC
  • GYNECOLOGIC CANCERS
    • Cervical Cancer
    • Endometrial Cancer
    • Ovarian Cancer
  • HEAD & NECK CANCERS
  • HEMATOLOGY
    • Bone Marrow & Stem Cell Transplant
  • IMMUNOTHERAPY
    • CAR T-Cell Therapy
  • LEUKEMIAS
    • AML
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • LUNG CANCER
    • MET-Targeted Therapy
    • Small Cell Lung Cancer
    • Biomarker-Driven Lung Cancer
    • EGFR+ Lung Cancer
  • LYMPHOMAS
    • DLBCL
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
  • MPNs
  • MULTIPLE MYELOMA
  • NTRK GENE FUSIONS
  • ONCOLOGY POLICY
  • SARCOMA
  • SKIN CANCERS
    • Melanoma
  • THYROID CANCERS
Spotlight -
Community Oncology Practice|
Oncology Policy|
Myeloma|
CLL|
Genomic Testing|
GU Cancers
Advertisement
Case Based Roundtable Logo

In Evolving Paradigms Roundtable events, leading myeloma specialists engage in peer-to-peer discussions on evolving treatment strategies and the practical application of new approaches in clinical practice.

  • ALL
  • BRAIN CANCER
  • BREAST CANCER
  • CHRONIC LYMPHOCYTIC LEUKEMIA
  • GENITOURINARY CANCERS
  • GI CANCERS
  • GYNECOLOGIC CANCERS
  • HCC
  • HEMATOLOGY
  • LEUKEMIAS
  • LUNG CANCER
  • LYMPHOMAS
  • MPNS
  • MULTIPLE MYELOMA
  • PROSTATE CANCER
  • RENAL CELL CARCINOMA
  • SARCOMA
  • SKIN CANCERS
  • THYROID CANCERS

Emerging Multiple Myeloma Therapies and Sequencing Decisions

Referral Before Salvage Therapy Keeps CAR T an Option in Myeloma
Referral Before Salvage Therapy Keeps CAR T an Option in Myeloma
November 12, 2026
During a live event, Rushang Patel, MD, PhD, and participants discussed referral timing, bridging, and payer barriers that shape access to cellular therapy in early relapsed multiple myeloma.
Costa Explains What Drives Survival Benefit With Tec/Dara in Myeloma
Costa Explains What Drives Survival Benefit With Tec/Dara in Myeloma
October 05, 2026
Luciano Costa, MD, PhD, explains the findings from a competing risk analysis of the MajesTEC-3 trial linking survival to reduced myeloma progression.
Advertisement
Advertisement
  • About Us
  • Advertise
  • Contact Us
  • CureToday.com
  • CancerNetwork.com
  • OncLive.com
  • OncNursingNews.com
  • Do Not Sell My Information
  • Privacy
  • Terms & Conditions
  • Editorial Board
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us